The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Branning Todd P. since 2020.
This trader's CIK number is 1765274.
At the time of last reporting, Branning Todd P. was the Chief Financial Officer of Neubase Therapeutics, Inc.. (stock ticker symbol NBSE).
Also see all insider trading activities at Neubase Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | AMRX | 0 | $0 | 0 | $0 | 20,096 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | NBSE | 30,000 | $51,700 | 0 | $0 | 0 | $0 |
1. Amneal Pharmaceuticals, Inc. (AMRX)
2. Neubase Therapeutics, Inc. (NBSE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-01-22 | AMRX | Option Ex | 20,096 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-18 | NBSE | Buy | 10,000 | 1.81 | 18,100 |
| 2022-03-17 | NBSE | Buy | 10,000 | 1.74 | 17,400 |
| 2022-03-16 | NBSE | Buy | 10,000 | 1.62 | 16,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Branning Todd P. (Chief Financial Officer of Neubase Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.